Subtype
Large Intestinal Neoplasm
CI-CAN-00001062Explore in graph →
Non-malignant1,846 active trials21 approved drugs383 evidence items
- NCIt
- C215201
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001062Explore in graph →
Clinical trials
8,846 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00532987 | Assessment of Health Related Quality of Life in Patients Treated for Rectal Cancer | terminated | — | 22 | Stanford UniversityOTHER | 1 | Feb 28, 2012 | clinicaltrials |
| NCT01212887 | Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer | terminated | Phase 1 | 14 | Cancer Research UKOTHER | 1 | Feb 28, 2012 | clinicaltrials |
| NCT01096381 | Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor | terminated | — | 8 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Feb 27, 2012 | clinicaltrials |
| NCT00969033 | CS-1008 Used With Irinotecan Versus Irinotecan Alone in Subjects With Metastatic Colorectal Carcinoma Who Failed First-line Treatment With Oxaliplatin | terminated | Phase 2 | 8 | Daiichi SankyoINDUSTRY | 1 | Jan 31, 2012 | clinicaltrials |
| NCT00296062 | Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal Cancer | terminated | Phase 1 | 12 | Case Comprehensive Cancer CenterOTHER | 1 | Jan 16, 2012 | clinicaltrials |
| NCT00860249 | Outreach for Patients That Are Newly Eligible for Colorectal Cancer Screening(UPQUAL) | terminated | N/A | 60 | Northwestern UniversityOTHER | 1 | Dec 5, 2011 | clinicaltrials |
| NCT00779311 | A Phase I Trial Evaluating mFOLFOX6 and Avastin With Nexavar as First-Line Treatment for Metastatic Colorectal Cancer | terminated | Phase 1 | 8 | Accelerated Community Oncology Research NetworkOTHER | 1 | Nov 2, 2011 | clinicaltrials |
| NCT01437826 | Antioxidant Supplement and Reduction of Metachronous Adenomas of the Large Bowel: a Double Blind Randomized Trial | terminated | Phase 3 | 411 | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, ItalyOTHER | 1 | Sep 21, 2011 | clinicaltrials |
| NCT00145665 | The Role of Fluorothymidine Positron Emission Tomography (FLT-PET) in Proliferation of Colorectal Liver Metastases | terminated | Phase 1 / Phase 2 | 80 | Radboud University Medical CenterOTHER | 1 | Sep 5, 2011 | clinicaltrials |
| NCT00898781 | Study of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic Cancer | terminated | — | 80 | Mayo ClinicOTHER | 1 | Jul 19, 2011 | clinicaltrials |
| NCT01126866 | Curative Resectability of Not Optimally Resectable Liver and/or Lung Metastases From Colorectal Carcinoma (CRC) Under Intensified Chemotherapy(APRIORI) | terminated | Phase 2 | 35 | National Center for Tumor Diseases, HeidelbergOTHER | 1 | Jul 15, 2011 | clinicaltrials |
| NCT00494611 | A Study of the Perioperative Use of Cetuximab in Colon Cancer Patients | terminated | Phase 1 | 25 | St. Luke's-Roosevelt Hospital CenterOTHER | 1 | May 19, 2011 | clinicaltrials |
| NCT00003365 | Sulindac and Plant Compounds in Preventing Colon Cancer | terminated | N/A | — | University of Medicine and Dentistry of New JerseyOTHER | 1 | Jan 27, 2011 | clinicaltrials |
| NCT00065117 | Safety, Tolerability and Efficacy of ZD6126 in Combination With Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects With Metastatic Colorectal Cancer. | terminated | Phase 2 | 180 | AstraZenecaINDUSTRY | 1 | Jan 26, 2011 | clinicaltrials |
| NCT01271166 | Glivec® Plus m-FOLFOX Avastin® in Advanced Colorectal Cancer | terminated | Phase 1 | 10 | Novartis PharmaceuticalsINDUSTRY | 1 | Jan 6, 2011 | clinicaltrials |
| NCT01196494 | Study of Intraoperative Colonic Irrigation Versus Stent Placement in Obstructive Left-Sided Colonic Cancer | terminated | N/A | — | Corporacion Parc TauliOTHER | 0 | Sep 8, 2010 | clinicaltrials |
| NCT00102024 | Safety and Activity of 90Y-Labeled IDEC-159 in Subjects With Metastatic Colorectal Adenocarcinoma | terminated | Phase 1 / Phase 2 | 30 | BiogenINDUSTRY | 1 | Aug 27, 2010 | clinicaltrials |
| NCT00106054 | Neoadjuvant Colorectal Cancer With Unresectable Liver Metastases | terminated | Phase 2 | 2 | PfizerINDUSTRY | 1 | Aug 27, 2010 | clinicaltrials |
| NCT01127425 | Length of Hospital Stay, Nursing Hours and Recovery After Laparoscopic Versus Open Colon Resection Without Fast Track | terminated | N/A | 18 | University Hospital, Gentofte, CopenhagenOTHER | 1 | Jun 7, 2010 | clinicaltrials |
| NCT00394615 | Metabolic Imaging Predict Histopathologic Response to Preop ChemoXRT for Locally Advanced Rectal CA | terminated | N/A | 15 | Stanford UniversityOTHER | 1 | Mar 29, 2010 | clinicaltrials |
| NCT00277303 | Study of XL999 in Patients With Metastatic Colorectal Cancer | terminated | Phase 2 | 17 | Symphony Evolution, Inc.INDUSTRY | 1 | Feb 22, 2010 | clinicaltrials |
| NCT00251186 | First-Line Capecitabine and Cetuximab for Metastatic Colorectal Ca in Elderly Patients | terminated | Phase 2 | 18 | University of Medicine and Dentistry of New JerseyOTHER | 1 | Jan 26, 2010 | clinicaltrials |
| NCT00677287 | Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Colorectal Cancer | terminated | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | Dec 29, 2009 | clinicaltrials |
| NCT00677612 | Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Colorectal Cancer | terminated | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | Dec 29, 2009 | clinicaltrials |
| NCT00259363 | Oxaliplatin in Rectal Cancer | terminated | Phase 1 / Phase 2 | 46 | SanofiINDUSTRY | 1 | Dec 7, 2009 | clinicaltrials |
| NCT00129870 | CONCEPT: Comparison of Oxaliplatin vs Conventional Methods With Calcium/Magnesium in First-Line Metastatic Colorectal Cancer | terminated | Phase 4 | 180 | SanofiINDUSTRY | 1 | Feb 13, 2009 | clinicaltrials |
| NCT00327093 | Elaboration of a Model for Predicting Efficacy of Monoclonal Antibodies (Cetuximab and Bevacizumab) in Patients With Colorectal Cancer and Liver Metastases | terminated | Phase 4 | 31 | Hospices Civils de LyonOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00320320 | Irinotecan Discontinuation and Reintroduction for Advanced Colorectal Cancer | terminated | Phase 2 | 72 | Gachon University Gil Medical CenterOTHER | 1 | Nov 25, 2008 | clinicaltrials |
| NCT00493857 | Study of Nimotuzumab and Irinotecan in Metastatic Colorectal Cancer | terminated | Phase 2 | 100 | YM BioSciencesINDUSTRY | 1 | Nov 17, 2008 | clinicaltrials |
| NCT00037180 | For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With Chemotherapy | terminated | Phase 2 | 212 | PfizerINDUSTRY | 1 | Sep 29, 2008 | clinicaltrials |
| NCT00419978 | The Significance of Sentinel Node Analysis in Colon Cancer | terminated | N/A | 24 | Legacy Health SystemOTHER | 1 | Jul 4, 2008 | clinicaltrials |
| NCT00399009 | Comparative Study of Circular Stapling Instruments | terminated | N/A | 880 | Uppsala University HospitalOTHER | 1 | Jun 9, 2008 | clinicaltrials |
| NCT00457327 | Pilot Study for Evaluation of the Need for Protective Ileostomy After Low Anterior Resection Due to Rectal Cancer | terminated | Phase 2 | 40 | Heidelberg UniversityOTHER | 1 | Jun 5, 2008 | clinicaltrials |
| NCT00249301 | A Study of MLN8054 in Patients With Advanced Solid Tumors | terminated | Phase 1 | 63 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Apr 1, 2008 | clinicaltrials |
| NCT00176787 | Radiation Therapy With Capecitabine in Rectal Cancer | terminated | Phase 2 | 30 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jan 10, 2008 | clinicaltrials |
| NCT00120172 | Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal Cancer | terminated | Phase 2 | 40 | Geriatric Oncology ConsortiumOTHER | 1 | Nov 16, 2007 | clinicaltrials |
| NCT00216424 | Capecitabine (Xeloda) and Radiation for Patients With Rectosigmoid Carcinoma | terminated | Phase 4 | 40 | James A. Haley Veterans Administration HospitalFED | 1 | Nov 12, 2007 | clinicaltrials |
| NCT00385021 | ChronoFOLFOX Plus Avastin for Patients With Metastatic Colorectal Cancer | terminated | Phase 2 | 20 | Southwestern Regional Medical CenterOTHER | 1 | Nov 2, 2007 | clinicaltrials |
| NCT00514332 | Comparison Between Colorectal Stents and Primary Surgery in Obstructive Colonic Cancer. A Randomized, Controlled Study | terminated | N/A | 70 | University Hospital, MontpellierOTHER | 0 | Aug 9, 2007 | clinicaltrials |
| NCT00506168 | Study of Irinotecan & Capecitabine in Metastatic Colorectal Cancer | terminated | Phase 2 | 37 | National Cancer Center, KoreaOTHER_GOV | 1 | Jul 25, 2007 | clinicaltrials |
| NCT00229567 | Intra-op Lidocaine and Ketamine Effect on Postoperative Bowel Function | terminated | N/A | 60 | University of SaskatchewanOTHER | 1 | Apr 19, 2007 | clinicaltrials |
| NCT00176761 | Tumor-Pulsed Dendritic Cells Used as a Tumor Vaccine | terminated | Phase 2 | 27 | University of Michigan Rogel Cancer CenterOTHER | 1 | Sep 11, 2006 | clinicaltrials |
| NCT00180960 | Treatment of a Cancerous Disease of the Peritoneum With Complete Cytoreductive Surgery and Intraperitoneal Chemohyperthermia | terminated | Phase 2 | 100 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Sep 11, 2006 | clinicaltrials |
| NCT00051688 | Tezacitabine and Oxaliplatin for the Treatment of Patients With Metastatic Colorectal Cancer | terminated | Phase 2 | — | Chiron CorporationINDUSTRY | 1 | Jul 11, 2006 | clinicaltrials |
| NCT00114946 | A Study to Compare Two Avastin-Based Treatment Regimens for the Treatment of Metastatic Colorectal Cancer | terminated | Phase 4 | 800 | Genentech, Inc.INDUSTRY | 0 | May 29, 2006 | clinicaltrials |
| NCT00209703 | Feasibility Study of mFOLFOX6 in Patients With Advanced Colorectal Cancer | terminated | Phase 2 | 30 | Hokkaido Gastrointestinal Cancer Study GroupOTHER | 1 | Apr 21, 2006 | clinicaltrials |
| NCT00309517 | Randomized Study on Neoadjuvant Radio-Chemotherapy in Rectal Carcinoma Dukes B and C | terminated | Phase 3 | 700 | Austrian Breast & Colorectal Cancer Study GroupNETWORK | 1 | Apr 3, 2006 | clinicaltrials |
| NCT00036517 | Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal Cancer | terminated | Phase 1 / Phase 2 | 30 | PhytoCeuticaINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Feb 28, 2012source: clinicaltrials